Argomenti e Notizie
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Anno 20°
Num. 128
Recens. 2486
Aderiamo allo standard HONcode per l'affidabilità dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
Nuova bibliografia selezionata fino al mese di ottobre 2015 (recensioni 26) Ordina per Autore - Titolo - Rivista
Managing Osteoporosis In Patients On Long-Term Bisphosphonate Treatment: Report Of A Task Force Of The American Society For Bone And Mineral Research.
Adler RA, Fuleihan GE, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE.
J Bone Miner Res. 2015 Sep 9. doi: 10.1002/jbmr.2708. [Epub ahead of print]

Duration Of Anti-resorptive Therapy For Osteoporosis.
Adler RA.
Endocrine. 2015 Oct 3. [Epub ahead of print]

Pathophysiology Of Osteonecrosis Of The Jaws.
Aghaloo T, Hazboun R, Tetradis S.
Oral Maxillofac Surg Clin North Am. 2015 Sep 24. pii: S1042-3699(15)00049-7. doi: 10.1016/j.coms.2015.06.001. [Epub ahead of print] Review.

Atypical Femur Fractures Associated With Diphosphonate Use.
Balach T, Baldwin PC, Intravia J.
J Am Acad Orthop Surg. 2015 Sep;23(9):550-7. doi: 10.5435/JAAOS-D-14-00024. Epub 2015 Jul 20. Review.

For How Long Should Osteoporosis Treatment Continue?
Boschitsch E.
Climacteric. 2015 Oct;18(5):675-7. doi: 10.3109/13697137.2015.1065061.

The Vertebral Fracture Cascade: Etiology And Clinical Implications.
Broy SB.
J Clin Densitom. 2015 Sep 9. pii: S1094-6950(15)00171-7. doi: 10.1016/j.jocd.2015.08.007. [Epub ahead of print] Review.

Bone Density After Teriparatide Discontinuation In Premenopausal Idiopathic Osteoporosis.
Cohen A, Kamanda-Kosseh M, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S, Bucovsky M, Stubby J, Shane E.
J Clin Endocrinol Metab. 2015 Sep 10:jc20152829. [Epub ahead of print]

Two Birds With One Stone: Possible Dual-Role Of Oxytocin In The Treatment Of Diabetes And Osteoporosis.
Elabd S, Sabry I.
Front Endocrinol (Lausanne). 2015 Aug 10;6:121. doi: 10.3389/fendo.2015.00121. eCollection 2015. Review.

The Impact Of Persistence With Bisphosphonates On Health Resource Utilization And Fracture Risk In The UK: A Study Of Patient Records From The UK Clinical Practice Research Datalink.
Ferguson S, Feudjo Tepie M, Taylor A, Roddam A, Critchlow C, Iqbal M, Spangler L, Bayly J.
J Eval Clin Pract. 2015 Aug 16. doi: 10.1111/jep.12422. [Epub ahead of print]

Hormone Replacement Therapy And The Prevention Of Postmenopausal Osteoporosis.
Gambacciani M, Levancini M.
Prz Menopauzalny. 2014 Sep;13(4):213-20. doi: 10.5114/pm.2014.44996. Epub 2014 Sep 9.

Short Term Safety Of Zoledronic Acid In Young Patients With Bone Disorders: An Extensive Institutional Experience.
George S, Weber D, Kaplan P, Hummel K, Monk HM, Levine MA.
J Clin Endocrinol Metab. 2015 Aug 26:jc20152680. [Epub ahead of print]

Treatment Of Vitamin D Insufficiency In Postmenopausal Women: A Randomized Clinical Trial.
Hansen KE, Johnson RE, Chambers KR, Johnson MG, Lemon CC, Vo TN, Marvdashti S.
JAMA Intern Med. 2015 Aug 3. doi: 10.1001/jamainternmed.2015.3874. [Epub ahead of print]

Change Of Bone Mineral Density And Biochemical Markers Of Bone Turnover In Patients On Suppressive Levothyroxine Therapy For Differentiated Thyroid Carcinoma.
Kim CW, Hong S, Oh SH, Lee JJ, Han JY, Hong S, Kim SH, Nam M, Kim YS.
J Bone Metab. 2015 Aug;22(3):135-41. doi: 10.11005/jbm.2015.22.3.135. Epub 2015 Aug 31.

Compliance And Persistence With Daily, Weekly, And Monthly Bisphosphonates For Osteoporosis In Japan: Analysis Of Data From The CISA.
Kishimoto H, Maehara M.
Arch Osteoporos. 2015;10:231. doi: 10.1007/s11657-015-0231-6. Epub 2015 Aug 22.

Impact Of The NOGG And NOF Guidelines On The Indication Of Bone Mineral Density In Routine Clinical Practice.
Kyriakos G, Vidal-Casariego A, Fernández-Martínez MN, Blanco-Suárez MD, Ballesteros-Pomar MD, Cano-Rodríguez I.
J Clin Densitom. 2015 Sep 3. pii: S1094-6950(15)00164-X. doi: 10.1016/j.jocd.2015.08.001. [Epub ahead of print]

Fracture Prediction From Repeat BMD Measurements In Clinical Practice.
Leslie WD, Brennan-Olsen SL, Morin SN, Lix LM.
Osteoporos Int. 2015 Aug 5. [Epub ahead of print]

The Efficacy Of Parathyroid Hormone Analogues In Combination With Bisphosphonates For The Treatment Of Osteoporosis: A Meta-Analysis Of Randomized Controlled Trials.
Li W, Chen W, Lin Y.
Medicine (Baltimore). 2015 Sep;94(38):e1156. doi: 10.1097/MD.0000000000001156.

Zoledronic Acid For Treatment Of Osteopenia And Osteoporosis In Women With Primary Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy: A 5-year Follow-up.
Majithia N, Atherton PJ, Lafky JM, Wagner-Johnston N, Olson J, Dakhil SR, Perez EA, Loprinzi CL, Hines SL.
Support Care Cancer. 2015 Aug 23. [Epub ahead of print]

[Omission Of Osteoporosis Diagnostics And Therapy After Fractures In The Elderly : An Avoidable Treatment Error?]
Neuerburg C, Heberer K, Heberer J.
Unfallchirurg. 2015 Sep 30. [Epub ahead of print] German.

Potential Mechanisms And Applications Of Statins On Osteogenesis: Current Modalities, Conflicts And Future Directions.
Oryan A, Kamali A, Moshiri A.
J Control Release. 2015 Oct 10;215:12-24. doi: 10.1016/j.jconrel.2015.07.022. Epub 2015 Jul 28. Review.

Strontium Ranelate As An Adjuvant For Fracture Healing: Clinical, Radiological, And Ultrasound Findings In A Randomized Controlled Study On Wrist Fractures.
Scaglione M, Fabbri L, Casella F, Guido G.
Osteoporos Int. 2015 Aug 21. [Epub ahead of print]

[On "2015 Guidelines For Prevention And Treatment Of Osteoporosis" . Osteoporosis Associated With Sex Hormone Depletion Treatment].
Takahashi S.
Clin Calcium. 2015;25(9):1357-65. doi: CliCa150913571365. Japanese.

Improving Bone Microarchitecture In Aging With Diosgenin Treatment: A Study In Senescence-Accelerated OXYS Rats.
Tikhonova MA, Ting CH, Kolosova NG, Hsu CY, Chen JH, Huang CW, Tseng GT, Hung CS, Kao PF, Amstislavskaya TG, Ho YJ.
Chin J Physiol. 2015 Oct 31;58(5). pii: CJP.2015.BAD325. doi: 10.4077/CJP.2015.BAD325. [Epub ahead of print]

Results Of A National Multicentric Study On Compliance To Treatment With Various Disphosphonate Formulations In Patients With Postmenopausal Osteoporosis.
Vinicola V, Giampà E, Di Bonito M, Ferretti V, Nuvoli G, Paoletti F, Piazzini M, Ranieri M, Tuveri MA.
Minerva Endocrinol. 2015 Sep;40(3):187-93.

Parathyroid Hormone Plus Alendronate In Osteoporosis: A Meta-Analysis Of Randomized Controlled Trials.
Wang C, Zhang G, Gu M, Fan J, Chen J, Zhang G, Li B.
J Invest Surg. 2015 Aug 13. [Epub ahead of print]

Safety Of Daily Teriparatide Treatment: A Post Hoc Analysis Of A Phase III Study To Investigate The Possible Association Of Teriparatide Treatment With Calcium Homeostasis In Patients With Serum Procollagen Type I N-terminal Propeptide Elevation.
Yamamoto T, Tsujimoto M, Sowa H.
Clin Interv Aging. 2015 Jul 6;10:1101-9. doi: 10.2147/CIA.S83549. eCollection 2015.

(Vers. 2.1)  Modificato il 6-10-2015   
questo sito aderisce ai principi HONCODE    disclaimer